EL SEGUNDO, Calif., July 21, 2017 -- PCM, Inc. (NASDAQ:PCMI) a leading technology solutions provider, announced that it will release its second quarter results on July 26, 2017 after the market closes. Management will discuss the second quarter results during a conference call to be held on Wednesday, July 26, 2017, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
This conference call will be webcast by NASDAQ OMX. The conference call will be available to the general public on the live webcast in a listen-only mode and can be accessed by going to PCM's website at http://investor.pcm.com/events.cfm.
The webcast will be archived and can be accessed at http://investor.pcm.com under “Events & Presentations.” A replay of the conference call by phone will be available from 7:30 p.m. ET on July 26, 2017 until August 2, 2017. The dial-in number for the replay is (855) 859-2056 or (404) 537-3406 and the pass code is 60371308.
PCM, Inc., through its wholly-owned subsidiaries, is a leading technology solutions provider to small and medium sized businesses, mid-market and enterprise customers, government and educational institutions, and individual consumers across the United States and Canada. We generated net sales of $2.3 billion in the twelve months ended March 31, 2017. For more information, please visit investor.pcm.com or call (310) 354-5600.
Investor Relations: Brett Maas Hayden IR (646) 536-7331 [email protected]


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



